%0 Journal Article %T Should we set-up routine screening for primary sclerosing cholangitis in all IBD patients? %+ Centre d'Investigation Clinique [Rennes] (CIC) %+ Nutrition, Métabolismes et Cancer (NuMeCan) %+ Monash University [Melbourne] %+ Groupe Immunité des Muqueuses et Agents Pathogènes (GIMAP) %+ Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E) %A Bouguen, Guillaume %A Sparrow, Miles Peter %A Roblin, Xavier %Z Ferring %Z Pfizer %Z Shire %Z Abbvie %Z MSD %Z Takeda %Z Janssen %Z Celgen %< avec comité de lecture %@ 1590-8658 %J Digestive and Liver Disease %I Elsevier %V 50 %N 11 %P 1176-1177 %8 2018-11 %D 2018 %R 10.1016/j.dld.2018.07.043 %M 30274792 %Z Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyJournal articles %G English %2 https://univ-rennes.hal.science/hal-01903476/document %2 https://univ-rennes.hal.science/hal-01903476/file/2018%20-%20Should%20we%20set-up%20routine%20screening%20for%20primary%20scl.pdf %L hal-01903476 %U https://univ-rennes.hal.science/hal-01903476 %~ INSERM %~ UNIV-ST-ETIENNE %~ UNIV-RENNES1 %~ UNIV-LYON1 %~ INRA %~ HL %~ CIC %~ CIC203 %~ STATS-UR1 %~ NUMECAN %~ NUMECAN-EXPRES %~ UR1-UFR-SVE %~ UR1-HAL %~ UR1-SDV %~ AGREENIUM %~ TEST-UR-CSS %~ UNIV-RENNES %~ CIRI %~ UDL %~ UR1-BIO-SA %~ CIRI-S-PAUL-GIMAP